Cargando…

Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study

Detalles Bibliográficos
Autores principales: Molina, Jesús, Plaza, Vicente, Nuevo, Javier, Gutiérrez, Martín, Sicras-Mainar, Antoni, Valero, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369590/
https://www.ncbi.nlm.nih.gov/pubmed/37496866
http://dx.doi.org/10.1016/j.opresp.2023.100232
_version_ 1785077790651973632
author Molina, Jesús
Plaza, Vicente
Nuevo, Javier
Gutiérrez, Martín
Sicras-Mainar, Antoni
Valero, Antonio
author_facet Molina, Jesús
Plaza, Vicente
Nuevo, Javier
Gutiérrez, Martín
Sicras-Mainar, Antoni
Valero, Antonio
author_sort Molina, Jesús
collection PubMed
description
format Online
Article
Text
id pubmed-10369590
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103695902023-07-26 Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study Molina, Jesús Plaza, Vicente Nuevo, Javier Gutiérrez, Martín Sicras-Mainar, Antoni Valero, Antonio Open Respir Arch Scientific Letter Elsevier 2023-01-13 /pmc/articles/PMC10369590/ /pubmed/37496866 http://dx.doi.org/10.1016/j.opresp.2023.100232 Text en © 2023 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Scientific Letter
Molina, Jesús
Plaza, Vicente
Nuevo, Javier
Gutiérrez, Martín
Sicras-Mainar, Antoni
Valero, Antonio
Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
title Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
title_full Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
title_fullStr Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
title_full_unstemmed Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
title_short Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
title_sort clinical consequences of the overuse of short-acting β2-adrenergic agonists (saba) in the treatment of asthma in spain: the sabina study
topic Scientific Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369590/
https://www.ncbi.nlm.nih.gov/pubmed/37496866
http://dx.doi.org/10.1016/j.opresp.2023.100232
work_keys_str_mv AT molinajesus clinicalconsequencesoftheoveruseofshortactingb2adrenergicagonistssabainthetreatmentofasthmainspainthesabinastudy
AT plazavicente clinicalconsequencesoftheoveruseofshortactingb2adrenergicagonistssabainthetreatmentofasthmainspainthesabinastudy
AT nuevojavier clinicalconsequencesoftheoveruseofshortactingb2adrenergicagonistssabainthetreatmentofasthmainspainthesabinastudy
AT gutierrezmartin clinicalconsequencesoftheoveruseofshortactingb2adrenergicagonistssabainthetreatmentofasthmainspainthesabinastudy
AT sicrasmainarantoni clinicalconsequencesoftheoveruseofshortactingb2adrenergicagonistssabainthetreatmentofasthmainspainthesabinastudy
AT valeroantonio clinicalconsequencesoftheoveruseofshortactingb2adrenergicagonistssabainthetreatmentofasthmainspainthesabinastudy